腹壁ヘルニアメッシュデバイス市場-世界の産業規模、シェア、動向、機会、予測、メッシュタイプ別、適応症別、手技別、最終用途別、地域別、競合別、2020年～2030年

腹壁ヘルニアメッシュデバイスの世界市場は、2024年には8億4,106万米ドルと評価され、2030年までには13億7,561万米ドルに達すると予測され、予測期間中のCAGRは8.52%で成長すると予測されています。

この市場を牽引しているのは、腹部ヘルニアの有病率の増加であり、多くの場合、肥満、過去の腹部手術、高齢化などと関連しています。これらのメッシュ器具は、弱くなった腹壁を補強し、再発のリスクを減らすことで、外科的修復において重要な役割を果たしています。

低侵襲手術の需要が高まるにつれ、患者の予後改善と合併症発生率の低下により、従来の縫合法よりもメッシュを用いた修復法が好まれるようになってきています。ヘルスケアシステムは、より早い回復と長期的な耐久性を重視しており、これが先進的なメッシュ製品の普及に寄与しています。軽量、吸収性、複合素材などのメッシュデザインにおける革新は、生体適合性、手術効率、患者の快適性を向上させています。患者の意識が高まり、研究開発への投資が増加していることから、世界の腹壁ヘルニアメッシュデバイス市場は持続的な成長を遂げようとしています。

主要な市場促進要因

腹部ヘルニアの有病率の上昇と関連リスク要因

主要な市場課題

アクセス性を制限する高度なメッシュデバイスの高コスト

主要な市場動向

軽量および複合メッシュ素材に対する需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • メッシュタイプ別（吸収性メッシュ、部分吸収性メッシュ、非吸収性メッシュ）
  • 適応症別（臍ヘルニア、上腹部ヘルニア、瘢痕ヘルニア、その他）
  • 手技別（開腹手術、腹腔鏡手術、ロボット手術、その他）
  • 用途別（入院施設、外来施設）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの腹壁ヘルニアメッシュデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Medtronic plc
• Becton, Dickinson and Company（BD）
• Meril Life Sciences Pvt. Ltd.
• Novus Scientific AB
• B. Braun SE
• TELA Bio, Inc.
• BG Medical LLC
• Integra LifeSciences Corporation
• W. L. Gore & Associates, Inc.
• Atrium Medical

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Ventral Hernia Mesh Devices Market was valued at USD 841.06 Million in 2024 and is projected to reach USD 1375.61 Million by 2030, growing at a CAGR of 8.52% during the forecast period. The market is driven by a growing prevalence of ventral hernias, often linked to obesity, prior abdominal surgeries, and aging populations. These mesh devices play a crucial role in surgical repairs by reinforcing weakened abdominal walls and reducing the risk of recurrence.

As the demand for minimally invasive procedures increases, mesh-based repairs are increasingly preferred over traditional suture methods due to improved patient outcomes and lower complication rates. Healthcare systems are placing greater emphasis on faster recovery and long-term durability, which is contributing to the widespread adoption of advanced mesh products. Innovations in mesh design-such as lightweight, absorbable, and composite materials-are enhancing biocompatibility, surgical efficiency, and patient comfort. With rising awareness among patients and increasing investments in research and development, the global ventral hernia mesh devices market is poised for sustained growth.

Key Market Drivers

Rising Prevalence of Ventral Hernias and Related Risk Factors

The increasing incidence of ventral hernias globally is a primary driver of market growth. In the United States alone, over 350,000 ventral hernia repair procedures are performed annually, underscoring the growing clinical need for effective treatment solutions. Prevalence is notably higher among individuals aged 45 and above, driven by factors such as tissue degeneration and obesity.

With approximately 600,000 repairs performed annually, as reported by the CDC, the demand for durable and reliable mesh devices is intensifying. Obesity-affecting over 40% of U.S. adults-contributes to elevated intra-abdominal pressure, further heightening the risk of hernia development. These statistics reflect a growing and persistent demand for mesh-based repair products that can provide long-term reinforcement and reduce recurrence rates.

Key Market Challenges

High Cost of Advanced Mesh Devices Limiting Accessibility

The high cost associated with advanced ventral hernia mesh products remains a key barrier to wider adoption, especially in low- and middle-income countries. These premium devices-often featuring bioresorbable materials or advanced composites-command elevated prices due to the use of proprietary technologies, strict regulatory requirements, and high production costs.

Hospitals operating under budget constraints and patients lacking robust insurance coverage may struggle to access these advanced solutions. In resource-limited settings, the preference often shifts toward less expensive or traditional repair methods, despite higher risks of complications. Even in developed markets, limited reimbursement for next-generation meshes can discourage surgeons from adopting the latest products, further slowing innovation diffusion and creating disparities in patient outcomes.

Key Market Trends

Rising Demand for Lightweight and Composite Mesh Materials

A notable trend in the ventral hernia mesh market is the shift toward lightweight and composite mesh materials that offer enhanced patient comfort and reduced post-operative complications. Conventional heavyweight meshes have been associated with adverse outcomes such as chronic pain and foreign body sensation.

Modern lightweight meshes, featuring larger pores and reduced material density, allow for better integration with host tissue and lower inflammatory responses. These design improvements contribute to more favorable healing, decreased fibrosis, and enhanced overall patient satisfaction. As surgeons seek safer, more effective solutions with fewer long-term risks, the demand for these advanced mesh materials continues to grow across both inpatient and outpatient settings.

Key Market Players

• Medtronic plc
• Becton, Dickinson and Company (BD)
• Meril Life Sciences Pvt. Ltd.
• Novus Scientific AB
• B. Braun SE
• TELA Bio, Inc.
• BG Medical LLC
• Integra LifeSciences Corporation
• W. L. Gore & Associates, Inc.
• Atrium Medical

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ventral Hernia Mesh Devices Market, By Mesh Type:

• Resorbable Mesh
• Partially Absorbable Mesh
• Non-Resorbable Mesh

Ventral Hernia Mesh Devices Market, By Indication:

• Umbilical Hernia
• Epigastric Hernia
• Incisional Hernia
• Others

Ventral Hernia Mesh Devices Market, By Procedure:

• Open Surgery
• Laparoscopic Surgery
• Robotic Surgery
• Others

Ventral Hernia Mesh Devices Market, By End Use:

• Inpatient Facilities
• Outpatient Facilities

Ventral Hernia Mesh Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ventral Hernia Mesh Devices Market.

Available Customizations:

Global Ventral Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Ventral Hernia Mesh Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh)
  • 5.2.2. By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others)
  • 5.2.3. By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others)
  • 5.2.4. By End Use (Inpatient Facilities, Outpatient Facilities)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Ventral Hernia Mesh Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Mesh Type
  • 6.2.2. By Indication
  • 6.2.3. By Procedure
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ventral Hernia Mesh Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Mesh Type
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Procedure
      • 6.3.1.2.4. By End Use
  • 6.3.2. Mexico Ventral Hernia Mesh Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Mesh Type
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Procedure
      • 6.3.2.2.4. By End Use
  • 6.3.3. Canada Ventral Hernia Mesh Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Mesh Type
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Procedure
      • 6.3.3.2.4. By End Use

7. Europe Ventral Hernia Mesh Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Mesh Type
  • 7.2.2. By Indication
  • 7.2.3. By Procedure
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Ventral Hernia Mesh Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Mesh Type
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Procedure
      • 7.3.1.2.4. By End Use
  • 7.3.2. Germany Ventral Hernia Mesh Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Mesh Type
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Procedure
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Ventral Hernia Mesh Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Mesh Type
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Procedure
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Ventral Hernia Mesh Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Mesh Type
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Procedure
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Ventral Hernia Mesh Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Mesh Type
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Procedure
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Ventral Hernia Mesh Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Mesh Type
  • 8.2.2. By Indication
  • 8.2.3. By Procedure
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Ventral Hernia Mesh Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Mesh Type
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Procedure
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Ventral Hernia Mesh Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Mesh Type
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Procedure
      • 8.3.2.2.4. By End Use
  • 8.3.3. South Korea Ventral Hernia Mesh Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Mesh Type
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Procedure
      • 8.3.3.2.4. By End Use
  • 8.3.4. Japan Ventral Hernia Mesh Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Mesh Type
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Procedure
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Ventral Hernia Mesh Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Mesh Type
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Procedure
      • 8.3.5.2.4. By End Use

9. South America Ventral Hernia Mesh Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Mesh Type
  • 9.2.2. By Indication
  • 9.2.3. By Procedure
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Ventral Hernia Mesh Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Mesh Type
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Procedure
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Ventral Hernia Mesh Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Mesh Type
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Procedure
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Ventral Hernia Mesh Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Mesh Type
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Procedure
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Ventral Hernia Mesh Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Mesh Type
  • 10.2.2. By Indication
  • 10.2.3. By Procedure
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Ventral Hernia Mesh Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Mesh Type
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Procedure
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Ventral Hernia Mesh Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Mesh Type
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Procedure
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Ventral Hernia Mesh Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Mesh Type
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Procedure
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Becton, Dickinson and Company (BD)
• 15.3. Meril Life Sciences Pvt. Ltd.
• 15.4. Novus Scientific AB
• 15.5. B. Braun SE
• 15.6. TELA Bio, Inc.
• 15.7. BG Medical LLC
• 15.8. Integra LifeSciences Corporation
• 15.9. W. L. Gore & Associates, Inc.
• 15.10. Atrium Medical

16. Strategic Recommendations

17. About Us & Disclaimer